OpenAlex
PricingAboutJobs
Log inGet started
Work

Weekly doxorubicinversus doxorubicin every 3 weeks in cyclophosphamide, doxorubicin, and cisplatin chemotherapy for non-small cell lung cancer

HTML

Year: 1989
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Cancer
DOI: 10.1002/1097-0142(19891115)64:10<1995::aid-cncr2820641004>3.0.co;2-l
Authors: Theera Umsawasdi, Manuel Valdivieso, Daniel J. Booser, H. Thomas Barkley, Michael Ewer, Bruce Mackay, Hari M. Dhingra, William K. Murphy, Gary Spitzer, Delia F. Chiuten, Calvin Dixon, Peter Farha, David T. Carr
Institution: The University of Texas MD Anderson Cancer Center
Language: English

Topic: Lung Cancer Diagnosis and Treatment
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: CAP chemotherapy, non-small cell lung cancer, cardiotoxicity, endomyocardial biopsy, cardiac monitoring, duration of response, granulocytopenia, fever, limited disease, extensive disease, adjuvant chemotherapy, survival, chemotherapy toxicity
SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute
Award: G1004735096
OpenAlex ID: W2083702415
FWCI:
Cites: 20
Cited by: 19
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms